Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edgar Ben-Josef

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
Cancers|March 6, 2021
Impact of FAPI-PET/CT on Target Volume Definition in Radiation Therapy of Locally Recurrent Pancreatic CancerJakob Liermann, Mustafa Syed, Edgar Ben-Josef, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2012
The quality-of-life effects of neoadjuvant chemoradiation in locally advanced rectal cancerJoseph M Herman, Amol K Narang, Kent A Griffith, et al.
Neoplasia (New York, N.Y.)|May 11, 2010
GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancerRichard L Watson, Aaron C Spalding, Steven P Zielske, et al.
Scientific Reports|June 13, 2015
Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic CancerMoumita Chatterjee, Edgar Ben-Josef, Dafydd G Thomas, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2024
Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancerUri Amit, Ugur Uslu, Ioannis I Verginadis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the PancreasEdgar Ben-Josef, Asha George, William F Regine, et al.
JCO Oncology Practice|February 14, 2022
Activity Monitoring for Toxicity Detection and Management in Patients Undergoing Chemoradiation for Gastrointestinal MalignanciesNishant K Shah, Kristine N Kim, Amardeep Grewal, et al.
The Journal of Clinical Endocrinology and Metabolism|June 21, 2019
Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical CarcinomaLaila A Gharzai, Michael D Green, Kent A Griffith, et al.
International Journal of Gastrointestinal Cancer|May 20, 2003
Prognostic Significance of the Labeling of Adnab-9 in Pancreatic Intraductal Papillary Mucinous NeoplasmsMartin Tobi, James Hatfield, Volkan Adsay, et al.
American Journal of Clinical Oncology|March 20, 2018
Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low ToxicityBrian C Baumann, Jenny Wei, John P Plastaras, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Cancers|March 6, 2021
Impact of FAPI-PET/CT on Target Volume Definition in Radiation Therapy of Locally Recurrent Pancreatic CancerJakob Liermann, Mustafa Syed, Edgar Ben-Josef, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2012
The quality-of-life effects of neoadjuvant chemoradiation in locally advanced rectal cancerJoseph M Herman, Amol K Narang, Kent A Griffith, et al.
Neoplasia (New York, N.Y.)|May 11, 2010
GSK3beta and beta-catenin modulate radiation cytotoxicity in pancreatic cancerRichard L Watson, Aaron C Spalding, Steven P Zielske, et al.
Scientific Reports|June 13, 2015
Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic CancerMoumita Chatterjee, Edgar Ben-Josef, Dafydd G Thomas, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2024
Proton radiation boosts the efficacy of mesothelin-targeting chimeric antigen receptor T cell therapy in pancreatic cancerUri Amit, Ugur Uslu, Ioannis I Verginadis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the PancreasEdgar Ben-Josef, Asha George, William F Regine, et al.
JCO Oncology Practice|February 14, 2022
Activity Monitoring for Toxicity Detection and Management in Patients Undergoing Chemoradiation for Gastrointestinal MalignanciesNishant K Shah, Kristine N Kim, Amardeep Grewal, et al.
The Journal of Clinical Endocrinology and Metabolism|June 21, 2019
Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical CarcinomaLaila A Gharzai, Michael D Green, Kent A Griffith, et al.
International Journal of Gastrointestinal Cancer|May 20, 2003
Prognostic Significance of the Labeling of Adnab-9 in Pancreatic Intraductal Papillary Mucinous NeoplasmsMartin Tobi, James Hatfield, Volkan Adsay, et al.
American Journal of Clinical Oncology|March 20, 2018
Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low ToxicityBrian C Baumann, Jenny Wei, John P Plastaras, et al.
Pageof 13